ORIC PHARMACEUTICALS INC
NASDAQ: ORIC (Oric Pharmaceuticals, Inc.)
Kemas kini terakhir: 1 jam lalu10.65
0.51 (5.03%)
| Penutupan Terdahulu | 10.14 |
| Buka | 10.01 |
| Jumlah Dagangan | 725,438 |
| Purata Dagangan (3B) | 1,218,755 |
| Modal Pasaran | 907,575,936 |
| Harga / Buku (P/B) | 3.33 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Aug 2025 |
| EPS Cair (TTM) | -1.88 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.97% |
| Nisbah Semasa (MRQ) | 12.00 |
| Aliran Tunai Operasi (OCF TTM) | -115.01 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -68.48 M |
| Pulangan Atas Aset (ROA TTM) | -30.87% |
| Pulangan Atas Ekuiti (ROE TTM) | -48.45% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Oric Pharmaceuticals, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | -4.0 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.80 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.93% |
| % Dimiliki oleh Institusi | 102.70% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Viking Global Investors Lp | 31 Mar 2025 | 6,572,700 |
| Nextech Invest, Ltd. | 31 Mar 2025 | 5,285,714 |
| Nextech Invest Ltd. | 31 Dec 2024 | 5,285,714 |
| Alkeon Capital Management Llc | 31 Mar 2025 | 4,004,096 |
| Column Group Llc | 31 Mar 2025 | 3,540,777 |
| Ecor1 Capital, Llc | 31 Mar 2025 | 3,418,068 |
| Vr Adviser, Llc | 31 Mar 2025 | 3,182,527 |
| Nea Management Company, Llc | 31 Mar 2025 | 2,195,545 |
| Vivo Capital, Llc | 31 Mar 2025 | 2,080,450 |
| Silverarc Capital Management, Llc | 31 Mar 2025 | 2,060,240 |
| First Turn Management, Llc | 31 Mar 2025 | 2,027,430 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 22.00 (HC Wainwright & Co., 106.57%) | Beli |
| Median | 17.00 (59.62%) | |
| Rendah | 12.00 (Oppenheimer, 12.68%) | Beli |
| Purata | 17.00 (59.62%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 5.06 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 09 May 2025 | 22.00 (106.57%) | Beli | 5.08 |
| 05 May 2025 | 21.00 (97.18%) | Beli | 5.70 | |
| Oppenheimer | 06 May 2025 | 12.00 (12.68%) | Beli | 5.04 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| PISCITELLI DOMINIC | - | 10.21 | -53,500 | -553,708 |
| YOU ANGIE | 9.66 | - | 28,000 | 261,648 |
| Jumlah Keseluruhan Kuantiti Bersih | -25,500 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -292,060 | |||
| Purata Pembelian Keseluruhan ($) | 9.66 | |||
| Purata Jualan Keseluruhan ($) | 10.21 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| PISCITELLI DOMINIC | Pegawai | 01 Jul 2025 | Jual automatik (-) | 20,000 | 10.14 | 202,800 |
| PISCITELLI DOMINIC | Pegawai | 24 Jun 2025 | Jual automatik (-) | 32,466 | 10.49 | 340,568 |
| YOU ANGIE | Pengarah | 23 Jun 2025 | Beli (+) | 1,403 | 10.00 | 14,030 |
| PISCITELLI DOMINIC | Pegawai | 23 Jun 2025 | Jual automatik (-) | 1,034 | 10.00 | 10,340 |
| YOU ANGIE | Pengarah | 20 Jun 2025 | Beli (+) | 26,597 | 9.31 | 247,618 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |